OUTCOME OF TRANSCATHETER AORTIC VALVE REPLACEMENT USING SAPIEN3 IN PATIENTS WITH EXTRA LARGE AORTIC ANNULUS
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY(2018)
摘要
Little is known about outcome of transcatheter aortic valve replacement (TAVR) using Sapien 3 (S3) (Edwards Lifescience, Irvine, CA) in patients with aortic annulus area of more than 683 mm2. The aim of this study is to investigate procedural outcomes and short-term mortality in patients with aortic
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要